Maturation of pluripotent stem cell-derived cardiomyocytes: limitations and challenges from metabolic aspects
Abstract Acute coronary syndromes, such as myocardial infarction (MI), lack effective therapies beyond heart transplantation, which is often hindered by donor scarcity and postoperative complications. Human induced pluripotent stem cells (hiPSCs) offer the possibility of myocardial regeneration by d...
Principais autores: | Xi Jiang, Xin Lian, Kun Wei, Jie Zhang, Kaihua Yu, Haoming Li, Haichun Ma, Yin Cai, Lei Pang |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
BMC
2024-10-01
|
coleção: | Stem Cell Research & Therapy |
Assuntos: | |
Acesso em linha: | https://doi.org/10.1186/s13287-024-03961-4 |
Registros relacionados
-
Maturation of induced pluripotent stem cell-derived cardiomyocytes and its therapeutic effect on myocardial infarction in mouse
por: Peng Wu, et al.
Publicado em: (2023-02-01) -
Characterization of cardiac metabolism in iPSC-derived cardiomyocytes: lessons from maturation and disease modeling
por: Sofija Vučković, et al.
Publicado em: (2022-07-01) -
iPSC-Derived Cardiomyocytes in Inherited Cardiac Arrhythmias: Pathomechanistic Discovery and Drug Development
por: Eline Simons, et al.
Publicado em: (2023-01-01) -
Modeling hypertrophic cardiomyopathy with human cardiomyocytes derived from induced pluripotent stem cells
por: Jiangtao Li, et al.
Publicado em: (2022-06-01) -
Metabolic Maturation Exaggerates Abnormal Calcium Handling in a <i>Lamp2</i> Knockout Human Pluripotent Stem Cell-Derived Cardiomyocyte Model of Danon Disease
por: Robert J. Barndt, et al.
Publicado em: (2022-12-01)